R Lorenc

7.9k total citations · 2 hit papers
98 papers, 3.5k citations indexed

About

R Lorenc is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, R Lorenc has authored 98 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Orthopedics and Sports Medicine, 31 papers in Molecular Biology and 26 papers in Pathology and Forensic Medicine. Recurrent topics in R Lorenc's work include Bone health and osteoporosis research (43 papers), Vitamin D Research Studies (24 papers) and Bone health and treatments (20 papers). R Lorenc is often cited by papers focused on Bone health and osteoporosis research (43 papers), Vitamin D Research Studies (24 papers) and Bone health and treatments (20 papers). R Lorenc collaborates with scholars based in Poland, United States and Belgium. R Lorenc's co-authors include Gayle E. Lester, T K Gray, Paul D. Miller, Eric Orwoll, Stuart Weiss, John Graham, David L. Kendler, Kristel Vandormael, Antonio Lombardi and Peter Pietschmann and has published in prestigious journals such as Science, New England Journal of Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

R Lorenc

97 papers receiving 3.3k citations

Hit Papers

Alendronate for the Treatment of Osteoporosis in Men 2000 2026 2008 2017 2000 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Lorenc Poland 26 2.0k 1.1k 785 713 679 98 3.5k
Pierre J. Meunier France 21 2.7k 1.3× 1.2k 1.1× 564 0.7× 1.0k 1.4× 1.1k 1.6× 30 4.1k
Sol Epstein United States 35 2.0k 1.0× 1.3k 1.2× 1.2k 1.5× 904 1.3× 629 0.9× 104 4.4k
Barbara P. Lukert United States 26 1.6k 0.8× 977 0.9× 585 0.7× 830 1.2× 585 0.9× 64 3.3k
Caje Moniz United Kingdom 31 1.3k 0.6× 752 0.7× 711 0.9× 849 1.2× 508 0.7× 64 3.4k
J. A. Eisman Australia 17 1.8k 0.9× 733 0.7× 613 0.8× 596 0.8× 857 1.3× 40 2.9k
Peder Charles Denmark 36 1.9k 1.0× 1.1k 1.0× 1.2k 1.5× 793 1.1× 465 0.7× 98 4.4k
L Miravet France 26 1.7k 0.8× 707 0.6× 838 1.1× 643 0.9× 823 1.2× 99 3.4k
Elisabetta Romagnoli Italy 33 1.3k 0.6× 922 0.8× 1.1k 1.3× 507 0.7× 503 0.7× 106 3.1k
M.A. Hansen Denmark 22 1.8k 0.9× 606 0.5× 463 0.6× 672 0.9× 687 1.0× 50 2.7k
Catherine Cormier France 33 2.9k 1.4× 1.3k 1.2× 1.3k 1.7× 1.1k 1.5× 1.0k 1.5× 118 4.8k

Countries citing papers authored by R Lorenc

Since Specialization
Citations

This map shows the geographic impact of R Lorenc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Lorenc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Lorenc more than expected).

Fields of papers citing papers by R Lorenc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Lorenc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Lorenc. The network helps show where R Lorenc may publish in the future.

Co-authorship network of co-authors of R Lorenc

This figure shows the co-authorship network connecting the top 25 collaborators of R Lorenc. A scholar is included among the top collaborators of R Lorenc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Lorenc. R Lorenc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
McCloskey, Eugène, Helena Johansson, Anders Odén, et al.. (2012). Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. Journal of Bone and Mineral Research. 27(7). 1480–1486. 106 indexed citations
3.
4.
Lorenc, R, et al.. (2010). Assessment of 10-year fracture risks in postmenopausal women by the FRAX™ algorithm, standardised for Italian, Spanish and UK populations. 9(1). 17–22. 1 indexed citations
5.
Płudowski, Paweł, et al.. (2009). Identification of vertebral deformities in the Polish population by morphometric X-ray absorptiometry - results of the EPOLOS study.. PubMed. 60(2). 68–75. 2 indexed citations
6.
Bogaczewicz, Jarosław, Anna Sysa‐Jędrzejowska, Tomasz Hawro, et al.. (2008). Original paper Requirement of vitamin D supplementation in patients with systemic lupus erythematosus. Reumatologia/Rheumatology. 46(4). 223–229. 1 indexed citations
7.
Płudowski, Paweł, Justyna Czech‐Kowalska, Luis del Río, et al.. (2007). Bone mass, density and body composition in preterm and full-term born children-preliminary results. Bone. 40(6). S71–S71. 2 indexed citations
8.
Płudowski, Paweł, et al.. (2006). Idiopathic juvenile osteoporosis – an analysis of the muscle-bone relationship. Osteoporosis International. 17(11). 1681–1690. 28 indexed citations
9.
Bianchi, M.L., Antonio Bossi, Danuta Chlebna‐Sokół, et al.. (2005). An international registry of fragility fractures in the young. Bone. 1 indexed citations
10.
Płudowski, Paweł, et al.. (2005). Reference Values for the Indicators of Skeletal and Muscular Status of Healthy Polish Children. Journal of Clinical Densitometry. 8(2). 164–177. 32 indexed citations
11.
Pawłowska, Joanna, Piotr Socha, Hor Ismail, et al.. (2004). Beneficial effect of liver transplantation on bone mineral density in small infants with cholestasis. Transplantation Proceedings. 36(5). 1479–1480. 8 indexed citations
12.
Adámi, S., Dieter Felsenberg, Claus Christiansen, et al.. (2004). Efficacy and safety of ibandronate given by intravenous injection once every 3 months. Bone. 34(5). 881–889. 75 indexed citations
13.
Reginster, Jean‐Yves, R Lorenc, Tim D. Spector, et al.. (2003). Strontium ranelate reduces the risk of non vertebral fractures in women with postmenopausal osteoporosis. Osteoporosis International. 14. 2 indexed citations
14.
Meunier, Pierre J., R Lorenc, Ian Smith, et al.. (2002). Strontium ranelate: new efficient anti-osteoporotic agent for treatment of vertebral osteoporosis in postmenopausal women. Open Repository and Bibliography (University of Liège). 7 indexed citations
15.
Lorenc, R. (2002). Idiopathic Juvenile Osteoporosis. Calcified Tissue International. 70(5). 395–397. 30 indexed citations
16.
Orwoll, Eric, Mark P. Ettinger, Stuart Weiss, et al.. (2000). Alendronate for the Treatment of Osteoporosis in Men. New England Journal of Medicine. 343(9). 604–610. 689 indexed citations breakdown →
17.
Meunier, P. J., D.O. Slosman, PD Delmas, et al.. (1997). Strontium ranelate as a treatment of vertebral osteoporosis. Open Repository and Bibliography (University of Liège). 11 indexed citations
18.
Łukaszkiewicz, Jacek, et al.. (1989). Simplified HPLC method for quantitation of vitamin D in blood serum. Journal of Pharmacological Methods. 21(4). 247–254. 2 indexed citations
19.
Pronicka, Ewa, et al.. (1988). Increased serum level of 1,25-dihydroxyvitamin D3 after parathyroid hormone in the normocalcemic phase of idiopathic hypercalcemia. The Journal of Pediatrics. 112(6). 930–933. 9 indexed citations
20.
Lester, Gayle E., T K Gray, & R Lorenc. (1978). Evidence for Maternal and Fetal Differences in Vitamin D Metabolism. Experimental Biology and Medicine. 159(2). 303–307. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026